MedTrace Logo

Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry

NCT01144780 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2020-04-09

No results posted yet for this study

Summary

The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.

Conditions

  • Myeloproliferative Disorders
  • Myeloproliferative Disorders (MPD)

Sponsors & Collaborators

Principal Investigators

  • Jason Robert Gotlib · Stanford University

  • Stephen Tracy Oh · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01144780 on ClinicalTrials.gov